FolioLanternBeta
GHGuardant Health, Inc.

Myrtle Potter

Director at Guardant Health, Inc., as of Jun 23, 2026Sold $206K of stock in the past 12 months: 100% under a disclosed plan.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
8.6%
share of stake sold at Guardant Health, Inc.
21K
shares held after the latest filing, Guardant Health, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
5
companies filed for

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
Oct 2025: $2K under a disclosed planOctNovDecJanFebMarAprMayJun 2026: $204K under a disclosed plan$204KJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Guardant Health, Inc. (GH)DirectorNov 10, 2021Jun 23, 2026
Immunovant, Inc. (IMVT)Former DirectorDec 20, 2019Dec 20, 2019
Axsome Therapeutics, Inc. (AXSM)Former DirectorJun 19, 2017Jun 10, 2019
INSMED Inc (INSM)Former DirectorDec 15, 2014May 17, 2018
Amazon (AMZN)Former DirectorApr 14, 2004Apr 13, 2009

Also a director at

Immunovant, Inc. (IMVT) (no filing in the last 18 months), Axsome Therapeutics, Inc. (AXSM) (no filing in the last 18 months), INSMED Inc (INSM) (no filing in the last 18 months), Amazon (AMZN) (no filing in the last 18 months)

Recent filings

The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.